Sometimes, patients may misunderstand the role of the social worker as part of the care team, but ultimately, they end up really being appreciative of the services, said Abra Kelson, MSW, LSWA-IC, medical social work supervisor, Northwest Medical Specialties.
Sometimes, patients may misunderstand the role of the social worker as part of the care team, but ultimately, they end up really being appreciative of the services, said Abra Kelson, MSW, LSWA-IC, medical social work supervisor, Northwest Medical Specialties.
Transcript
As a social worker who is part of a care management team, do you run into situations where patients see a stigma around needing help from a social worker or misunderstand what your role is?
Yea, all the time. I think I’ve actually played with the idea of not introducing myself as a social worker but rather, I’m a licensed mental health professional. Or, just because depending on their experience with a social worker, maybe their families or their friend, they can relate it to CPS [Child Protective Services]—[they think] you’re the one that takes kids away or you’re the one that makes us do things we don’t want to. But then other times people have had experience with social workers and they’re like, “oh my god a social worker, oh thank you for coming. I just want to meet with the social worker because I know that they’re the person that can help with resources and support and those types of things.”
You kind of hear both. But I find that when I do get that initial reaction, those people end up really being appreciative of my services, and I think that maybe I change that stigma for them.
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
Sarcoma Care: Biomarker Advancements Shape the Future
October 24th 2024At the regional Institute for Value-Based Medicine® event in Boston, Vinayak Venkataraman, MD, medical oncologist at Dana-Farber Cancer Institute and Harvard Medical School, was a panelist for the discussion, “Recent Advancements in Identifying Predictive Biomarkers for Sarcomas."
Read More
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
Sarcoma Care: Biomarker Advancements Shape the Future
October 24th 2024At the regional Institute for Value-Based Medicine® event in Boston, Vinayak Venkataraman, MD, medical oncologist at Dana-Farber Cancer Institute and Harvard Medical School, was a panelist for the discussion, “Recent Advancements in Identifying Predictive Biomarkers for Sarcomas."
Read More
2 Commerce Drive
Cranbury, NJ 08512